NO20056000L - Vevsbeskyttende cytokiner for beskyttelse, gjenoppbygging og okning av responsivceller, vev og organer med et utvidet terapeutisk vindu - Google Patents
Vevsbeskyttende cytokiner for beskyttelse, gjenoppbygging og okning av responsivceller, vev og organer med et utvidet terapeutisk vinduInfo
- Publication number
- NO20056000L NO20056000L NO20056000A NO20056000A NO20056000L NO 20056000 L NO20056000 L NO 20056000L NO 20056000 A NO20056000 A NO 20056000A NO 20056000 A NO20056000 A NO 20056000A NO 20056000 L NO20056000 L NO 20056000L
- Authority
- NO
- Norway
- Prior art keywords
- tissue
- protection
- reconstruction
- organs
- enhancement
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Zoology (AREA)
- Psychiatry (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Ophthalmology & Optometry (AREA)
- Virology (AREA)
- Addiction (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
- Obesity (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
Abstract
Det er tilvelebragt fremgangsmåter og anvendelser av et farmasøytisk preparat med et erytropoetin eller et vevsbeskyttende cytokin til beskyttelse og restituering av funksjon i en responsiv celle, vev, organ eller kroppsdelsfunksjon eller levedyktighet i pattedyr, når det administreres utenfor det terapeutiske vinduet til allerede godkjente terapeutika
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47166103P | 2003-05-19 | 2003-05-19 | |
PCT/US2004/015733 WO2004112693A2 (en) | 2003-05-19 | 2004-05-19 | Tissue protective cytokines with an extended therapeutic window |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20056000L true NO20056000L (no) | 2006-02-20 |
Family
ID=33539032
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20056000A NO20056000L (no) | 2003-05-19 | 2005-12-16 | Vevsbeskyttende cytokiner for beskyttelse, gjenoppbygging og okning av responsivceller, vev og organer med et utvidet terapeutisk vindu |
Country Status (13)
Country | Link |
---|---|
US (1) | US20090258821A1 (no) |
EP (1) | EP1633305A2 (no) |
JP (1) | JP2007505159A (no) |
KR (1) | KR20060013547A (no) |
CN (1) | CN1946416A (no) |
BR (1) | BRPI0410470A (no) |
CA (1) | CA2526096A1 (no) |
EA (1) | EA200501828A1 (no) |
IL (1) | IL172035A0 (no) |
IS (1) | IS8156A (no) |
MX (1) | MXPA05012515A (no) |
NO (1) | NO20056000L (no) |
WO (1) | WO2004112693A2 (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030072737A1 (en) * | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
RU2341284C2 (ru) * | 2003-03-27 | 2008-12-20 | Янссен Фармацевтика Нв | Применение эритропоэтина в восстановлении после инсульта |
US7718363B2 (en) | 2003-04-25 | 2010-05-18 | The Kenneth S. Warren Institute, Inc. | Tissue protective cytokine receptor complex and assays for identifying tissue protective compounds |
WO2006014349A2 (en) * | 2004-07-02 | 2006-02-09 | The Kenneth S. Warren Institute, Inc. | Method of producing fully carbamylated erythropoietin |
ATE429444T1 (de) * | 2004-07-07 | 2009-05-15 | Lundbeck & Co As H | Neues carbamyliertes epo und verfahren zu dessen herstellung |
US9345745B2 (en) | 2005-04-29 | 2016-05-24 | Bo Wang | Methods for treating inflammatory disorders and traumatic brain injury using stabilized non-hematopoietic EPO short peptides |
WO2007052154A2 (en) | 2005-04-29 | 2007-05-10 | University Of Medicine And Dentistry Of New Jersey | Erythropoietin-derived short peptide and its mimics as immuno/inflammatory modulators |
US9585932B2 (en) | 2005-04-29 | 2017-03-07 | Peter C. Dowling | Use of EPO-derived peptide fragments for the treatment of neurodegenerative disorders |
US20070072795A1 (en) * | 2005-09-28 | 2007-03-29 | Anton Haselbeck | Treatment of neurodegenerative disorders |
TW201129374A (en) * | 2009-10-26 | 2011-09-01 | Lundbeck & Co As H | Use of carbamylated erythropoietin for the treatment of Friedreich's ataxia |
US9956265B2 (en) * | 2011-04-26 | 2018-05-01 | Ajou University Industry-Academic Cooperation Foundation | Composition for aiding surgical procedures for treating ischemic vascular diseases |
CA2839630A1 (en) | 2011-06-24 | 2012-12-27 | Nono Inc. | Combination therapy for ischemia |
US9241970B2 (en) | 2011-12-13 | 2016-01-26 | Nono Inc. | Therapy for subarachnoid hemorrhage and ischemia |
US10695402B2 (en) * | 2017-03-16 | 2020-06-30 | University Of Rochester | Erythropoietin for gastrointestinal dysfunction |
RU2762892C1 (ru) * | 2021-02-18 | 2021-12-23 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ коррекции микроциркуляторных нарушений сетчатки асиалированным эритропоэтином |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6531121B2 (en) * | 2000-12-29 | 2003-03-11 | The Kenneth S. Warren Institute, Inc. | Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
US20030072737A1 (en) * | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
US7300915B2 (en) * | 2002-06-05 | 2007-11-27 | The Regents Of The University Of California | Use of erythropoietin and erythropoietin mimetics for the treatment of neuropathic pain |
US20040091961A1 (en) * | 2002-11-08 | 2004-05-13 | Evans Glen A. | Enhanced variants of erythropoietin and methods of use |
RU2341284C2 (ru) * | 2003-03-27 | 2008-12-20 | Янссен Фармацевтика Нв | Применение эритропоэтина в восстановлении после инсульта |
-
2004
- 2004-05-19 WO PCT/US2004/015733 patent/WO2004112693A2/en active Application Filing
- 2004-05-19 CA CA002526096A patent/CA2526096A1/en not_active Abandoned
- 2004-05-19 MX MXPA05012515A patent/MXPA05012515A/es not_active Application Discontinuation
- 2004-05-19 EA EA200501828A patent/EA200501828A1/ru unknown
- 2004-05-19 KR KR1020057022113A patent/KR20060013547A/ko not_active Application Discontinuation
- 2004-05-19 EP EP04752708A patent/EP1633305A2/en not_active Withdrawn
- 2004-05-19 JP JP2006533223A patent/JP2007505159A/ja not_active Withdrawn
- 2004-05-19 CN CNA2004800208589A patent/CN1946416A/zh active Pending
- 2004-05-19 BR BRPI0410470-6A patent/BRPI0410470A/pt not_active IP Right Cessation
-
2005
- 2005-11-17 IL IL172035A patent/IL172035A0/en unknown
- 2005-11-18 US US11/283,024 patent/US20090258821A1/en not_active Abandoned
- 2005-11-29 IS IS8156A patent/IS8156A/is unknown
- 2005-12-16 NO NO20056000A patent/NO20056000L/no unknown
Also Published As
Publication number | Publication date |
---|---|
MXPA05012515A (es) | 2006-05-25 |
EA200501828A1 (ru) | 2006-08-25 |
EP1633305A2 (en) | 2006-03-15 |
WO2004112693A2 (en) | 2004-12-29 |
US20090258821A1 (en) | 2009-10-15 |
WO2004112693A3 (en) | 2006-06-29 |
CN1946416A (zh) | 2007-04-11 |
JP2007505159A (ja) | 2007-03-08 |
KR20060013547A (ko) | 2006-02-10 |
CA2526096A1 (en) | 2004-12-29 |
IL172035A0 (en) | 2009-02-11 |
IS8156A (is) | 2005-11-29 |
BRPI0410470A (pt) | 2006-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20056000L (no) | Vevsbeskyttende cytokiner for beskyttelse, gjenoppbygging og okning av responsivceller, vev og organer med et utvidet terapeutisk vindu | |
PL377146A1 (pl) | Cytokiny ochronne dla tkanek do ochrony, odnowy i wzmacniania reaktywnych komórek, tkanek i narządów | |
PH12016500941A1 (en) | Protection, restoration, and enhancement for erythropoietin-responsive cells, tissues and organs | |
NO20075046L (no) | Gastroresistente farmasoytiske formuleringer inneholdende rifaximin | |
BRPI0818183A2 (pt) | reparo e regeneração do tecido renal usando células derivadas do tecido do cordão umbilical humano | |
WO2004009767A3 (en) | Cell therapy for regeneration | |
ATE366547T1 (de) | Implantat zur okklusion eines körperkanals | |
WO2005091956A3 (en) | In vitro test system for predicting patient tolerability of therapeutic agents | |
WO2004034890A3 (en) | Biological scaffolding material | |
DE69030880D1 (de) | Zusammensetzung zur Stimulierung des Immunsystems | |
EA200600076A1 (ru) | Композиции и способы увеличения активности теломеразы | |
BRPI0515332A (pt) | composições e seus usos para deficiências das enzimas lisossÈmicas | |
DE602004017194D1 (de) | Pyridylpyrrol-derivate als wirksame kinase-hemmer | |
BR112012004395B8 (pt) | plasmídeo fator 1 derivado de célula de estroma (sdf-1) e preparação injetável compreendendo referido plasmídeo | |
NO20065904L (no) | Terapeutiske forbindelser | |
NO20055136L (no) | Farmasoytisk sammensetning som innbeffatter et immunosuppressivt stoff for bruk ved behandling av hudsykdommer | |
DE60324094D1 (de) | Verwendung einer proteinkinase a-inaktivierenden verbindung in einer kosmetisch verträglichen zusammensetzung zur aufhellung der haut | |
AU2005221582A8 (en) | Tissue repair with multipotent cells | |
WO2006062935A3 (en) | Methods of reducing the incidence of rejection in tissue transplantation through the prophylactic use of recombinant human antihrombin | |
NO20082098L (no) | Formuleringer av AICA-ribosid | |
DE602004023183D1 (de) | Gegen antikörper gerichtete photodynamische therapie | |
NO20051261L (no) | Morfin-6-glukuronidsalt | |
NO20062506L (no) | Vevsbeskyttende cytokiner for beskyttelse, gjenopprettelse og oking av responsive celler, vev og organer med et forlenget terapeutisk vindu | |
WO2005084364A3 (en) | Long acting tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs | |
ATE396989T1 (de) | DIBENZOøC CHROMEN-6-ON DERIVATE ALS MITTEL GEGEN KREBS |